Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The effects of acute renal denervation on kidney perfusion and metabolism in experimental septic shock

  • Emiel Hendrik Post1,
  • Fuhong Su1,
  • Koji Hosokawa1,
  • Fabio Silvio Taccone1,
  • Antoine Herpain1,
  • Jacques Creteur1,
  • Daniel De Backer1 and
  • Jean-Louis Vincent1Email author
BMC NephrologyBMC series – open, inclusive and trusted201718:182

https://doi.org/10.1186/s12882-017-0586-6

Received: 28 November 2016

Accepted: 16 May 2017

Published: 31 May 2017

Abstract

Background

Perfusion deficits likely play an important role in the development of renal dysfunction in sepsis. Renal denervation may improve kidney perfusion and metabolism.

Methods

We randomized 14 female sheep to undergo bilateral surgical renal denervation (n = 7) or sham procedure (n = 7) prior to induction of sepsis. Renal blood flow (RBF) was measured with a pre-calibrated flowprobe. Laser Doppler probes were implanted to measure cortical and medullary perfusion. Cortical glucose, lactate and pyruvate levels were measured using the microdialysis technique. Creatinine clearance was determined. Sepsis was induced by peritonitis and fluid resuscitation was provided to avoid hypovolemia.

Results

RBF and cortical perfusion were higher in the denervated group during the first 6 h after induction of sepsis (P < 0.001 and P < 0.05, respectively), while medullary perfusion decreased similarly in both groups. After hypotension developed, RBF decreased to similar levels in both groups. Cortical pyruvate and lactate levels were lower in the denervated animals (P < 0.001 and P < 0.001, respectively). There were no differences between groups in creatinine clearance, urine output or time to oliguria.

Conclusion

Denervation thus caused an early increase in RBF that was distributed towards the kidney cortex. Although associated with an attenuation of early cortical metabolic alterations, denervation failed to prevent the deterioration in renal function.

Keywords

Acute kidney injury Sepsis Septic shock Renal blood flow Renal function

Background

Sepsis and septic shock are frequently complicated by acute kidney injury (AKI) [13] but its underlying pathogenesis remains poorly understood and therapeutic options are limited [4]. Several experimental studies have indicated a potential association between perfusion deficits and renal dysfunction in endotoxemia and sepsis [58], but others have demonstrated increased renal blood flow (RBF) in septic AKI, suggesting a limited role for hypoperfusion and tissue hypoxia in the development of sepsis-associated renal dysfunction [9]. Most human studies have shown a reduction in relative RBF, or fraction of cardiac output directed to the kidneys, indicating that perfusion-metabolism mismatch may occur [1012]. Attempts to manipulate RBF in sepsis have, however, been largely ineffective [13, 14].

While the importance of increased renal sympathetic outflow is well-established in the context of chronic arterial hypertension [15, 16], it is less clear whether elevated renal sympathetic nerve activity (RSNA) is equally relevant in acute disease [17]. In a rat model of endotoxemia, Wang et al. found that chronic renal denervation protected kidney function, an effect that was likely mediated by the preservation of RBF [18]. Conversely, in an ovine model of hyperdynamic sepsis caused by infusion of live bacteria, chronic denervation had no effect on RBF or kidney function [19]. However, acute, as opposed to chronic, renal denervation results in an immediate increase in RBF that may be sustained for several weeks or more [20, 21]. This immediate, but potentially transient, effect of renal denervation may be of particular value in early sepsis, as many of the factors contributing to the need for renal denervation will disappear once sepsis resolves.

Given the controversial role of RBF in sepsis-associated AKI and the acute effects of renal denervation on renal perfusion, we designed a study to evaluate the effects of acute renal denervation in a large animal model of septic shock. We hypothesized that acute renal denervation would augment renal perfusion in sepsis and attenuate the occurrence of renal dysfunction.

Methods

We studied 14 adult female sheep (laboratory-owned domestic animals, aged 8–10 months, weight 28 [2433] kg) that were fasted for 18 h prior to the start of the experiment with free access to water. The animals were deeply sedated with intravenous ketamine, midazolam and morphine throughout the experiment and were observed until spontaneous death. The ethical committee of the Free University of Brussels approved the study, and handling of the animals was in accordance with the ARRIVE guidelines [22].

Anesthesia and ventilation

The animals were premedicated with an intramuscular injection of 0.5 mg/kg midazolam (Dormicum; Roche SA, Anderlecht, Belgium) and 40 mg/kg ketamine (Imalgine; Merial, Lyon, France). A 14G peripheral cannula was introduced into the cephalic vein to provide vascular access. The animals underwent endotracheal intubation following induction of anesthesia with 30 μg/kg fentanyl citrate (Janssen Pharmaceutica, Beerse, Belgium) and 0.5 mg/kg of rocuronium bromide (Esmeron, Organon, Oss, The Netherlands). Sedation and analgesia during the surgical procedure were achieved using midazolam at a rate of 1.5 mg/kg/h, ketamine hydrochloride at 10 mg/kg/h, and morphine at 1.0 mg/kg/h. Mechanical ventilation was performed in volume-controlled mode with tidal volumes of 10 mL/kg and PEEP set at 5 cmH2O. The respiratory rate was adjusted to maintain PaCO2 values between 35 and 45 mmHg. Fraction of inspired oxygen (FiO2) was set at a value of 30% and adjusted to keep PaO2 > 80 mmHg. A 60-cm tube was inserted into the stomach to drain its content and left in situ to prevent rumen distension. A 14F Foley catheter (Beiersdorf AG; Hamburg, Germany) was introduced into the bladder to monitor urine output (UO).

Surgical preparation

The left carotid artery was surgically exposed and a 4.5 F arterial catheter (Vygon; Cirencester, England) was introduced to enable blood sampling and monitoring of the arterial pressure. A 7F introducer was inserted into the right jugular vein and a pulmonary artery catheter (CCO; Edwards LifeSciences Corp., Irvine, California) advanced under monitoring of waveforms. A midline laparotomy was then performed. The cecum was punctured and feces were extracted and stored at room temperature. The cecum was closed and returned to the abdominal cavity. The abdomen was closed in two layers and a tube was inserted through the abdominal wall for later injection of feces. The animals were then turned to the prone position. A bilateral flank incision was performed and the renal artery was identified on both sides. A flow probe (PS series 6 mm; Transonic, Ithaca, NY) was carefully positioned around the left renal artery.

Experimental protocol

After placement of the flow-probe, the animals were allowed to rest for approximately 1 hour after which the first baseline measurements were taken (T-1, Fig. 1). The animals were then randomized to either bilateral denervation (denervation, n = 7) or sham procedure (control, n = 7) using the envelope method. Renal denervation was performed by surgically stripping the renal artery from its adventitia and applying 20% phenol in 95% alcohol solution for 15 min while carefully avoiding damage to the surrounding tissues [19, 23]. An immediate increase in RBF was considered evidence of successful denervation [18, 19]. During the sham procedure, the adventitia was left untouched and the artery was moistened with a 0.9% NaCl-solution.
Fig. 1

Flowchart of the experimental protocol

A 3F catheter was then introduced into the renal vein using the Seldinger technique. The kidney fascia was carefully punctured and a microdialysis catheter (membrane length 4 mm, cut-off 20 kDa; CMA 20; Microdialysis, Solna, Sweden) was introduced into the renal cortex. A second puncture was made to insert a laser Doppler probe (OxyFlo; Optronix, Oxford, United Kingdom) to enable cortical perfusion measurements. A final puncture provided access for the insertion of a laser Doppler probe into the renal medulla. To avoid traumatic injury by dislocation, the probes were inserted after surgical denervation and, therefore, no Doppler measurements were taken at T-1.

All variables were then measured (T0) before injection of 1.5 g/kg of autologous feces into the abdominal cavity to induce peritonitis [24, 25]. Fluid resuscitation consisted of 6% hydroxyethyl starch (HES) (Voluven; Fresenius Kabi, Schelle, Belgium) and Ringer’s lactate (Baxter SA, Lessines, Belgium) given in a 1:1 ratio and titrated to PAOP. The maintenance rate was set at 4 mL/kg/h and fluid challenges of 100 mL Ringer’s lactate solution and 100 mL HES 6% were given if PAOP fell below its baseline value. When SV increased more than 10%, the fluid infusion rate was increased by 2 mL/kg/h [24, 25]. If MAP decreased to <65 mmHg in the absence of fluid-responsiveness, shock was considered refractory [26] and fluid infusion was set at a constant rate of 10 mL/kg/h. Since hypoglycemia commonly occurs in this sheep model, we monitored blood glucose concentrations by arterial blood gas analysis and attempted to keep these at baseline levels via the administration of boluses of 50% glucose.

Hemodynamics and general monitoring

Cardiac output and heart rate (HR) were monitored continuously. Mean arterial pressure (MAP) and pulmonary artery balloon-occluded pressure (PAOP) were obtained at end-expiration. Hourly arterial and mixed venous blood gas samples were taken to measure pH, hemoglobin (Hb, g/dL), monitor plasma glucose (mg/dL) and mixed venous oxygen saturation (SvO2; %), enabling the calculation of the systemic oxygen delivery index (DO2I; mL/min/m2), oxygen consumption index (VO2I; mL/min/m2), oxygen extraction ratio (O2ER; %) and the veno-arterial PCO2 difference (Pv-aCO2; mmHg). P/F ratio was defined as the ratio of partial pressure of arterial oxygen to FiO2. Cardiac index (CI; L/min/m2) and systemic vascular resistance index (SVRI; dynes·s/cm5/m2) were calculated according to standard formulas. Body surface area (BSA) was calculated for each animal according to a previously published formula [27].

Renal hemodynamics and kidney function

Left RBF (mL/min) was recorded hourly and the ratio of RBF to cardiac output, or relative RBF, was calculated (RBF/cardiac output; %). Renal DO2I, renal VO2I and renal O2ER were also calculated according to standard formulas. Renal vein blood was aspirated carefully to avoid contamination with inferior vena cava blood. Laser Doppler values were measured continuously in arbitrary blood perfusion units (BPU). UO was assessed hourly. Every 3 hours, a one-hour urine collection was obtained for measurement of urine creatinine and sodium content. In addition, a blood sample was taken for determination of plasma creatinine (mg/dL) and plasma sodium concentrations (mmol/L). Creatinine clearance (mL/min), filtration fraction (FF, %), sodium reabsorption (TNa+, mmol/min) and fractional excretion of sodium (FENa, %) were calculated according to standard formulas.

Assessment of renal cortex metabolism

The microdialysis catheter was perfused with a dedicated perfusion fluid (CMA T1; CMA Microdialysis AB; Na+ 147 mmol/L, K+ 4 mmol/L, Ca2+ 2.3 mmol/L, Cl 156 mmol/L, osmolality 290 mOsm/kg). The perfusion-rate was set at 0.3 μL/min (miniaturized infusion pump CMA107; CMA Microdialysis AB). The time needed for adequate equilibration depends on the metabolites of interest and is thought to be between 60 and 120 min [28]. We chose to collect the perfusate every 60 min in microvials, after a one-hour stabilization and washout period. Samples were analyzed for lactate (lactatecortex, mmol/L), pyruvate (pyruvatecortex, μmol/L) and glucose (glucosecortex, mg/dL) by a bedside analyzer (CMA600 Microdialysis Analyzer; CMA Microdialysis AB). The lactate/pyruvate ratio (cortical L/P ratio) was calculated as lactatecort/pyruvatecort × 1000. The mean cortical L/P ratio for all animals in which it has been measured in our lab is 18.9 ± 6.9 and we therefore considered values of 32.7 or more (mean + 2 × SD) as abnormal. The gradients between plasma and interstitial lactate (ΔLactatecortex) and pyruvate (ΔPyruvatecortex) were calculated by subtracting plasma from interstitial levels for lactate and pyruvate, respectively.

Measurement of plasma epinephrine

Blood samples were collected every 6 h, placed on ice and centrifuged at 5000 rpm for 10 min. The supernatant was immediately collected and stored at −80 °C. Plasma epinephrine concentrations (μg/L) were determined using a high-performance liquid chromatography electrochemical detection technique [29]. This technique has a limit of detection of 0.06 μg/L and a limit of quantitation of 0.19 μg/L.

Measurement of plasma pyruvate

Plasma pyruvate (μmol/L) was determined every 6 hours. Blood samples were immediately deproteinized by the addition of 8% perchloric acid (Sigma Aldrich, Machelen, Belgium) and centrifuged at 8000 rpm. The supernatant was then stored at −20 °C. Plasma pyruvate levels were measured using the enzymatic-UV method with linearity between 30 and 450 μmol/L and a measurement error of 3.7% [30].

Statistical analysis

Data were truncated at 18 h and are presented as mean ± standard deviation. Linear mixed effects models were used to test for the main effects of group and time and their interaction. When a significant effect of time was observed, a Student’s paired t-test was carried out to compare variables at each time-point with their respective baseline values. In case of significant interaction between group and time, Student’s t-test was performed to compare the groups at each time-point. Time to event analyses were carried out using a Log-Rank test and are presented as median and [range]. Two-sided tests were used and a P-value of less than 0.05 was considered statistically significant. Analyses were performed using the R statistical data environment (R, version 3.1.1; R Coreteam, Vienna, Austria).

Results

General findings and systemic hemodynamics

The two groups had similar baseline variables before randomization (T-1, Table 1). At T0, CI had increased transiently and SVRI decreased in the denervated animals compared to their values at T-1. MAP decreased similarly in both groups throughout the experiment and time to hypotension, defined as MAP <65 mmHg, was also similar (Table 2). PAOP was adequately maintained in all animals throughout the experiment and, after induction of sepsis, CI remained at baseline levels in both the denervation and control groups. The amount of fluid administered was similar in the two groups. The P/F ratio decreased similarly in both groups. Plasma epinephrine increased similarly in both groups (Table 3). Systemic lactate and pyruvate concentrations were not significantly different in the two groups at any time point. Survival times were similar in the two groups (Table 2).
Table 1

General hemodynamics and ventilation over time in the two groups of animals

 

T-1

T0

T3

T6

T9

T12

T15

T18

HR, beats/min

 Control

98 ± 12

95 ± 12

108 ± 12

108 ± 16

110 ± 9*

108 ± 14

116 ± 24

111 ± 38

 Denervation

96 ± 10

109 ± 10

112 ± 24*

113 ± 23*

102 ± 19

112 ± 25

117 ± 30

106 ± 35

CI, L/min/m2

 Control

5.3 ± 1.1

5.2 ± 1.4

5.4 ± 1.2

5.4 ± 1.3

5.4 ± 1.6

4.5 ± 1.4

4.5 ± 1.9

3.7 ± 1.8

 Denervation

4.8 ± 1.0

6.5 ± 1.2*

5.9 ± 1.9

6.1 ± 1.2

4.9 ± 1.2

4.5 ± 1.5

3.8 ± 1.6

3.8 ± 2.3

MAP, mmHg

 Control

88 ± 11

85 ± 7

81 ± 13

73 ± 21

59 ± 19*

43 ± 8*

39 ± 7*

33 ± 7*

 Denervation

90 ± 10

85 ± 6

86 ± 12

78 ± 9*

62 ± 18*

48 ± 9*

43 ± 11*

41 ± 13*

SVRI, dynes·s/cm5/m2

 Control

1300 ± 270

1308 ± 290

1236 ± 448

1063 ± 340*

828 ± 204*

720 ± 181*

659 ± 172*

640 ± 225*

 Denervation

1460 ± 198

1028 ± 199*

1187 ± 362

990 ± 136*

920 ± 186*

843 ± 217*

889 ± 349*

950 ± 685

SvO2, %

 Control

73.6 ± 4.4

74.3 ± 4.8

75.8 ± 8.0

77.8 ± 7.0

74.4 ± 9.3

70.8 ± 9.7

68.9 ± 8.0

54.3 ± 10.0

 Denervation

76.0 ± 6.0

80.9 ± 2.9

78.4 ± 3.6

82.5 ± 3.0

77.9 ± 2.9

73.3 ± 4.8

64.8 ± 14.5

56.1 ± 18.9

Fluid administered, mL

 Control

536 ± 78

978 ± 186*

2238 ± 239*

3610 ± 336*

4790 ± 399*

5816 ± 457*

6662 ± 470*

7506 ± 469*

 Denervation

632 ± 87

1328 ± 278*

2650 ± 375*

3800 ± 516*

4630 ± 533*

5528 ± 486*

6336 ± 486*

7328 ± 442*

PAOP, mmHg

 Control

4 ± 2

4 ± 2

4 ± 2

5 ± 2

4 ± 2

5 ± 3

5 ± 4

7 ± 4

 Denervation

5 ± 2

4 ± 2

4 ± 2

4 ± 3

5 ± 3

5 ± 2

5 ± 2

6 ± 3

P/F

 Control

477 ± 50

478 ± 70

442 ± 111

427 ± 148

395 ± 177

366 ± 180

313 ± 175*

187 ± 146*

 Denervation

467 ± 47

457 ± 63

426 ± 71

435 ± 53*

384 ± 76*

318 ± 108*

265 ± 119*

231 ± 126*

HR heart rate, CI cardiac index, MAP mean arterial pressure, SVRI systemic vascular resistance index, SvO 2 mixed venous oxygen saturation, PAOP pulmonary artery balloon-occluded pressure

*p < 0.05 vs. baseline

Table 2

Time to event analyses in the two groups of animals

 

Control, h

Denervation, h

p (Log Rank)

Shock (hours until MAP <65 mmHg)

8 [3–11]

9 [7–11]

0.805

Renal hypoperfusion (hours until 0.5 × baseline)

11 [4–18]

10 [9–18]

0.759

LPRcortex (hours until >32.7)

16 [10–18]

14 [8–18]

0.664

Oliguria (hours until UO < 0.5 mL/kg/h)

11 [6–18]

10 [6–12]

0.964

Plasma creatinine (hours until 1.5 × baseline)

14 [9–18]

12 [9–15]

0.492

Creatinine clearance (hours until 0.5 × baseline)

12 [6–12]

11 [6–12]

0.665

Survival (hours from baseline)

21 [18–24]

21 [18–25]

0.496

Data are presented as median [range]

MAP mean arterial pressure, LPR cortex cortical lactate/pyruvate ratio, UO urine output

Table 3

Systemic metabolism over time in the two groups of animals

 

T-1

T0

T3

T6

T9

T12

T15

T18

DO2I, L/min/m2

 Control

645 ± 162

598 ± 102

685 ± 157

687 ± 143

688 ± 223

578 ± 199

537 ± 175

366 ± 122*

 Denervation

617 ± 133

763 ± 121*

749 ± 238

759 ± 184*

677 ± 165

597 ± 187

486 ± 23

458 ± 390

VO2I, L/min/m2

 Control

177 ± 38

164 ± 33

167 ± 49

155 ± 36

162 ± 37

147 ± 43

137 ± 25*

129 ± 55

 Denervation

148 ± 19

156 ± 9

157 ± 34

139 ± 48

147 ± 37

157 ± 49

141 ± 48

142 ± 68

O2ER, %

 Control

28 ± 5

28 ± 4

25 ± 9

23 ± 8

24 ± 6

26 ± 6

28 ± 8

35 ± 9

 Denervation

25 ± 6

21 ± 3

22 ± 2

18 ± 3*

22 ± 4

27 ± 4

32 ± 11

38 ± 12

Hb, g/dL

 Control

8.6 ± 0.6

8.4 ± 1.0

9.2 ± 1.1

9.2 ± 0.9

9.5 ± 0.6*

9.7 ± 0.4*

9.4 ± 0.9*

9.3 ± 1.2

 Denervation

9.3 ± 1.0

8.6 ± 0.8*

9.2 ± 1.2

9.1 ± 1.5

10.2 ± 1.7

10.1 ± 1.7

9.6 ± 1.5

9.2 ± 1.5

Epinephrine, μg/L

 Control

-

0.18 ± 0.08

-

0.26 ± 0.06

-

1.05 ± 0.63*

-

3.10 ± 2.25*

 Denervation

-

0.22 ± 0.16

-

0.50 ± 0.39

-

1.22 ± 0.58*

-

2.33 ± 1.39*

Glucose, mg/dL

 Control

60 ± 10

57 ± 13

56 ± 18

47 ± 6*

45 ± 11

45 ± 11

52 ± 11

48 ± 8*

 Denervation

58 ± 10

54 ± 6

52 ± 14

53 ± 9

51 ± 14

47 ± 11

51 ± 11

52 ± 24

Lactate, mmol/L

 Control

1.1 ± 0.3

1.0 ± 0.3

1.1 ± 0.5

1.2 ± 0.6

1.9 ± 0.9*

3.5 ± 2.1*

6.2 ± 3.6*

10.8 ± 3.9*

 Denervation

1.2 ± 0.3

1.5 ± 0.4

1.3 ± 0.9

1.5 ± 0.8

2.3 ± 0.8*

2.9 ± 1.1*

4.5 ± 1.4*

8.1 ± 3.5*

Pyruvate, μmol/L

 Control

43 ± 8

36 ± 5

54 ± 19

68 ± 19*

92 ± 15*

148 ± 22*

202 ± 43*

208 ± 26*

 Denervation

47 ± 11

55 ± 24

55 ± 21

83 ± 26*

102 ± 33*

127 ± 21*

155 ± 29*

224 ± 50*

Pv-aCO2, mmHg

 Control

4.7 ± 2.4

4.9 ± 0.9

4.8 ± 1.9

5.0 ± 1.7

5.6 ± 2.5

7.2 ± 3.3

7.5 ± 3.2

12.9 ± 7.0*

 Denervation

5.7 ± 1.0

3.5 ± 1.5*

4.8 ± 1.9

4.7 ± 1.5

5.7 ± 1.8

6.1 ± 2.1

9.7 ± 4.2

10.5 ± 7.2

DO 2 I oxygen delivery index, VO 2 I oxygen consumption index, O 2 ER oxygen extraction ratio, Hb hemoglobin, P v-a CO 2 veno-arterial carbon dioxide tension difference

*p < 0.05 vs. baseline

Renal hemodynamics and metabolism

Absolute and relative RBF increased immediately after the denervation procedure and both were higher at T0 in the denervated than in the non-denervated animals. RBF in the control group was decreased at T0 compared to T-1 (Fig. 2). Cortical perfusion and RBF were higher in denervated than in non-denervated animals until 6 h after the induction of sepsis while medullary perfusion decreased similarly in both groups (Fig. 3). Renal VO2 decreased over time in both groups (Table 4). Cortical pyruvate and lactate increased significantly in the control group from 3 and 9 h, respectively, after induction of sepsis (Fig. 4). Cortical pyruvate in the denervated animals remained unchanged while cortical lactate increased after 13 h of sepsis. Cortical lactate was lower in the denervated animals than in the controls from 15 h after sepsis (p < 0.001). ΔPyruvatecortex was different between the groups from T6, suggesting that the interstitial changes largely reflected local alterations (Table 4). ΔLactatecortex increased similarly in both groups.
Fig. 2

Evolution of left renal blood flow (RBF) in denervated (n = 7, open circles) and control (n = 7, filled circles) animals. Data are presented as mean ± SEM. *p < 0.05 vs. baseline, #p < 0.05 vs. control

Fig. 3

Changes in cortical (circles) and medullary (triangles) laser Doppler values in denervated (n = 7, open symbols) and control (n = 7, filled symbols) animals. Data are presented as mean ± SEM. #p < 0.05 cortical laser Doppler denervated vs. control., *p < 0.05 cortical laser Doppler vs. baseline in denervated animals, §p < 0.05 cortical laser Doppler vs. baseline in control animals, $p < 0.05 medullary laser Doppler vs. baseline in denervated animals, &p < 0.05 medullary laser Doppler vs. baseline in control animals. To avoid the risk of traumatic injury, probes were inserted after surgical denervation

Table 4

Renal hemodynamics and metabolism over time in the two groups of animals

 

T-1

T0

T3

T6

T9

T12

T15

T18

RBF, mL/min

 Control

194 ± 48

157 ± 24*

121 ± 36*

116 ± 62*

84 ± 61*

44 ± 28*

37 ± 30*

31 ± 29*

 Denervation

163 ± 69

237 ± 59*,#

213 ± 50*,#

186 ± 36#

109 ± 64

64 ± 42*

43 ± 39*

38 ± 35*

RBF/CO, %

 Control

4.8 ± 0.2

4.1 ± 33

2.9 ± 0.8*

2.6 ± 0.9*

1.8 ± 0.1*

1.2 ± 0.5*

0.9 ± 0.5*

0.8 ± 0.7*

 Denervation

4.5 ± 0.2

4.9 ± 9

5.0 ± 1.5#

4.1 ± 0.9#

2.8 ± 1.7

1.9 ± 0.8*

1.2 ± 0.9*

1.3 ± 0.1*

Renal DO2I, mL/min/m2

 Control

-

14.3 ± 4

12.2 ± 4.1

11.6 ± 6.7

8.2 ± 6.8

4.1 ± 2.9*

4.0 ± 2.4*

2.7 ± 1.8*

 Denervation

-

21.6 ± 3

21.1 ± 7.8#

17.8 ± 5.3

10.9 ± 5.7*

6.3 ± 4.0*

4.2 ± 3.8*

3.5 ± 3.4*

Renal VO2I, mL/min/m2

 Control

-

2.0 ± 1.0

1.7 ± 0.6

1.3 ± 0.5

1.1 ± 0.5*

0.9 ± 0.5*

0.9 ± 0.2*

0.9 ± 0.3*

 Denervation

-

1.9 ± 0.8

1.9 ± 0.5

1.4 ± 0.4

1.0 ± 0.4*

1.2 ± 0.6

0.6 ± 0.3*

0.7 ± 0.6*

Renal O2ER, %

 Control

-

14 ± 4

15 ± 5

13 ± 5

20 ± 11

32 ± 19

33 ± 21

45 ± 23

 Denervation

-

10 ± 6

10 ± 3

8 ± 3

11 ± 6

21 ± 10

32 ± 24

31 ± 16

Laser Dopplercortex, BPU

 Control

-

42 ± 9

46 ± 7

43 ± 14

42 ± 26

26 ± 19*

19 ± 15*

14 ± 13*

 Denervation

-

59 ± 10#

60 ± 11#

59 ± 14#

47 ± 21

35 ± 25

28 ± 26*

26 ± 17

Laser Dopplermedulla, BPU

 Control

-

18 ± 7

20 ± 11.0

21 ± 11

19 ± 10

16 ± 12

11 ± 9*

10 ± 9*

 Denervation

-

19 ± 11

20 ± 10

23 ± 12

17 ± 14

12 ± 8

7 ± 6*

9 ± 8*

Lactatecortex, mmol/L

 Control

-

0.5 ± 0.3

0.8 ± 0.3*

0.7 ± 0.3

0.9 ± 0.4*

1.5 ± 0.7*

2.6 ± 0.9*

4.5 ± 1.2*

 Denervation

-

0.7 ± 0.2

0.9 ± 0.4

0.9 ± 0.3

0.9 ± 0.3

1.3 ± 0.6

1.6 ± 0.4*,#

2.5 ± 0.8*,#

ΔLactatecortex, mmol/L

 Control

-

−0.3 ± 0.3

−0.3 ± 0.3

−0.5 ± 0.3

−1.0 ± 0.6*

−2.1 ± 1.6*

−3.8 ± 3.1*

−6.6 ± 3.3*

 Denervation

-

−0.8 ± 0.3

−0.3 ± 0.5

−0.5 ± 0.5

−1.3 ± 0.7

−1.4 ± 1.1

−2.8 ± 1.5*

−5.6 ± 3.4*

Pyruvatecortex, mmol/L

 Control

-

27 ± 11

41 ± 23*

42 ± 13*

62 ± 26*

75 ± 29*

76 ± 49*

66 ± 46.0

 Denervation

-

30 ± 6

36 ± 10

32 ± 6

35 ± 11#

41 ± 23#

35 ± 22

22 ± 17#

ΔPyruvatecortex, mmol/L

 Control

-

−10 ± 10

−17 ± 10

−27 ± 21*

−41 ± 13*

−91 ± 38*

−150 ± 51*

−150 ± 51*

 Denervation

-

−26 ± 21

−18 ± 11

−50 ± 17*,#

−67 ± 16*,#

−82 ± 27*

−115 ± 22*

−200 ± 32*,#

LPRcortex, mmol/L

 Control

-

19.3 ± 6

21.9 ± 6.7

17.5 ± 8.3

17 ± 6.8

22.7 ± 161.1

51.2 ± 43.7

137.7 ± 126.2

 Denervation

-

26.3 ± 5.7

25.7 ± 6.2

29.2 ± 9.8

28.5 ± 12.5

43 ± 36.4

74.8 ± 52.9*

177.9 ± 106.3*

Glucosecortex, mg/dL

 Control

-

21 ± 8

18 ± 7

22 ± 12

25 ± 9

22 ± 13

21 ± 15

18 ± 17

 Denervation

-

26 ± 5

25 ± 7

25 ± 6

23 ± 8

25 ± 10

22 ± 13

12 ± 11*

RBF renal blood flow, RBF/CO relative renal blood flow, DO 2 I oxygen delivery index, VO 2 I oxygen consumption index, O 2 ER oxygen extraction ratio, ΔLactate cortex plasma to cortical lactate gradient, ΔPyruvate cortex plasma to cortical pyruvate gradient, LPR cortex cortical lactate/pyruvate ratio

*p < 0.05 vs. baseline, # p < 0.05 vs. control

Fig. 4

Changes in interstitial lactate (a) and pyruvate (b) in the renal cortex of denervated (n = 7, open circles) and control (n = 7, filled circles) animals. Data are presented as mean ± SEM. *p < 0.05 vs. baseline, #p < 0.05 vs. control

Renal function

Creatinine clearance decreased similarly in both groups (Table 5). Time to oliguria, defined as UO < 0.5 mL/kg/h, and time to increased plasma creatinine, defined as 1.5 times baseline, were similar in the denervated and control groups (Table 2).
Table 5

Renal function over time in the two groups of animals

 

T-1

T0

T3

T6

T9

T12

T15

T18

UO, mL/h

 Control

57 ± 31

62 ± 36

71 ± 41

51 ± 16

39 ± 66

3 ± 4*

2 ± 4*

1 ± 2*

 Denervation

66 ± 47

84 ± 70

84 ± 46

53 ± 23*

37 ± 20

10 ± 10*

1 ± 3*

0 ± 0*

Fluid balance, mL/h

 Control

211 ± 79

369 ± 168*

749 ± 145*

1256 ± 180*

1723 ± 195*

2209 ± 284*

2625 ± 304*

3043 ± 311*

 Denervation

260 ± 114

625 ± 221*,#

912 ± 286*

1315 ± 355*

1600 ± 366*

2003 ± 355*

2394 ± 365*

2860 ± 386*

Creatinine clearance, mL/min

 Control

61 ± 17

61 ± 18

80 ± 42

59 ± 42

45 ± 51

5 ± 6*

2.0 ± 0.4*

1 ± 2*

 Denervation

77 ± 43

54 ± 29

62 ± 27

58 ± 32

42 ± 30

7 ± 8*

1.9 ± 0.6*

0 ± 0*

Plasma creatinine, mg/dL

 Control

0.9 ± 0.1

0.9 ± 0.1

0.8 ± 0.1*

0.8 ± 0.1

1.0 ± 0.4

1.6 ± 0.4*

2.0 ± 0.4*

2.5 ± 0.5*

 Denervation

0.7 ± 0.2

0.8 ± 0.2

0.8 ± 0.2

0.7 ± 0.2

0.9 ± 0.3

1.4 ± 0.5*

1.9 ± 0.6*

2.3 ± 0.9*

FF, %

 Control

21 ± 8

22 ± 7

32 ± 14

25 ± 14

21 ± 19

4 ± 4*

1 ± 2*

0 ± 1*

 Denervation

27 ± 10

15 ± 6*

20 ± 10

20 ± 9

27 ± 24

8 ± 7

1 ± 1*

0 ± 0*

TNa+, mmol/min

 Control

8.4 ± 2.4

8.4 ± 2.6

11.4 ± 6.4

9.0 ± 5.4

7.2 ± 7.0

0.8 ± 0.8*

0.3 ± 0.6*

0.1 ± 0.2*

 Denervation

10.5 ± 4.2

7.2 ± 4.1

8.2 ± 3.6

7.8 ± 4.3

5.7 ± 4.3

1.0 ± 1.1*

0.1 ± 0.2*

0.0 ± 0.0*

FENa+, %

 Control

1.4 ± 1.0

1.3 ± 0.5

1.3 ± 0.5

1.0 ± 0.6

0.8 ± 0.7

0.4 ± 0.5

0.0 ± 0.0*

0.0 ± 0.0*

 Denervation

2.2 ± 1.6

1.9 ± 1.5

2.2 ± 1.6

1.4 ± 0.8

1.3 ± 1.1

0.9 ± 1.2

0.0 ± 0.0*

0.0 ± 0.0*

UO urine output, FF filtration fraction, TNa + sodium reabsorption, FENa + fractional excretion of sodium

*p < 0.05 vs. baseline, # p < 0.05 vs. control

Discussion

Renal denervation effectively increased RBF and cortical perfusion during early, normotensive sepsis whereas medullary flow was unaffected. The increase in RBF was transient and, after hypotension, values in denervated animals decreased to the same levels as in controls. Cortical pyruvate increased during early sepsis in the non-denervated animals but remained unchanged in the denervated group. The late increase in cortical lactate seemed to be attenuated in the denervated animals, although this may also reflect lower systemic values. Approximately 13 h after induction of sepsis, the cortical L/P ratio increased rapidly in both groups, reflecting the development of tissue hypoxia [31, 32]. This increase appeared more pronounced in the denervated group. There were no differences in the evolutions of plasma creatinine, creatinine clearance, urine output or in time to oliguria. There were no differences in survival between the groups.

Findings on the impact of kidney perfusion on renal function in sepsis are contradictory. For example, Johannes et al. reported that renal dysfunction with hypoperfusion was more severe in endotoxemic rats than in flow-matched healthy controls [33]. In an ovine model of infused live bacteria, Langenberg et al. reported an increased RBF associated with a decrease in creatinine clearance [9]. In at least one study on renal perfusion in human septic AKI, the absolute value of RBF, assessed with phase-contrast magnetic resonance imaging, was increased compared to healthy controls [11]. However, a consistent decrease in relative RBF, i.e., the fraction of cardiac output directed to the kidneys, was also observed [10, 11]. This suggests that there may still be substantial perfusion-metabolism mismatch that warrants therapeutic intervention. Indeed, in two models of porcine sepsis, Benes et al. showed that this flow redistribution separated the animals with and without renal dysfunction [34]. The selective decrease in RBF may be the result of several factors, including the intrinsic properties of renal autoregulation, the release of intrarenal vasoconstrictors and possibly increased sympathetic input [3538].

Attempts to selectively increase RBF have not always been successful [13, 14]. We recently reported that the administration of fenoldopam in our ovine model of experimental septic shock failed to preserve RBF or improve renal function [39]. In the present study, acute denervation caused an increase in cortical perfusion and a doubling of RBF in the early phase of sepsis. It also reduced cortical pyruvate levels, suggesting an attenuation of glycolytic activity in this phase [40].

Hyperlactatemia in septic shock may be caused primarily by tissue hypoperfusion and hypoxia, but adrenergic induction of aerobic glycolysis by circulating epinephrine, through β2 stimulation, likely also contributes [41, 42]. Renal denervation, however, did not alter plasma epinephrine levels and it appears that local tissue metabolism was affected by the change in RBF, possibly through a reduction in renal vascular resistance that was evident during the first few hours [4345].

Although renal denervation augmented cortical perfusion, it did not affect medullary flow at any stage. The renal medulla is sparsely innervated and so any effect of reduced RSNA was unlikely to benefit this part of the kidney, which is thought to be in a continuous state of near-hypoxia [20, 46]. A recent study in ovine sepsis suggested that medullary ischemia may be implicated in the development of septic AKI, and the intrarenal redistribution of blood flow that followed denervation could explain the absence of any beneficial effect on renal function [47].

The effect of denervation on RBF and cortical perfusion disappeared after the onset of shock, and was followed by a reduction in renal VO2 and an elevated cortical L/P ratio. It therefore seems that the flow redistribution during septic shock, which occurred in the absence of any renal sympathetic input, still resulted in a relevant perfusion-metabolism mismatch. Moreover, the increase in the cortical L/P ratio in this phase seemed more pronounced in the denervated animals, suggesting that flow was less efficiently matched to metabolism. This, and the associated trend to a lower renal O2ER, is in line with experiments showing that alpha blockade is associated with impaired oxygen extraction and earlier onset of tissue hypoxia [48, 49].

Several limitations might complicate the interpretation of our findings.

First, using HES 6% as a resuscitation fluid may have negatively affected renal function in our model [50]. However, a certain amount of colloid administration is necessary to limit edema formation, and human albumin could not be given. Moreover, the total amount of HES given was limited and we believe HES will have had only a minor, if any, effect on renal function in our model.

Second, fluid resuscitation was initiated immediately following the induction of sepsis, preventing us from observing the effects of early renal hypoperfusion. Given that early oxygenation deficits have been proposed to be a reflection of an upstream perfusion deficit [51], augmenting renal perfusion in non-resuscitated sepsis could have resulted in a different response than the one we observed.

Third, the microdialysis technique does not allow direct observation of the mechanisms underlying changes in interstitial metabolite concentrations. For example, increased renal oxygenation of lactate or gluconeogenesis could also explain lower pyruvate and lactate concentrations [5254]. Alternatively, increased pyruvate dehydrogenase (PDH) activity may have contributed to lower lactate and pyruvate levels during early sepsis [5557]. This would, however, be in contrast with studies that have shown an increased PDH activity by norepinephrine in white and brown adipose tissue in vivo [58] and in isolated hepatocytes and myocardial cells [59, 60]. Moreover, norepinephrine induces systemic gluconeogenesis and a renal effect in the same direction by denervation seems unlikely [61, 62]. Similarly, mitochondrial dysfunction could have contributed to the higher cortical L/P ratios that were observed in the denervated animals during septic shock [63].

Fourth, as we wanted to study the effects of denervation in the absence of pharmacological interference, we did not administer any vasopressor agents. We therefore cannot directly translate our data to situations in which MAP would be corrected. Similar reasoning applies to other supportive measures, such as source control or the administration of antibiotics.

Fifth, application of acute renal denervation in a less lethal model may have had different, possibly even beneficial, effects on kidney function. However, Calzavacca et al. [19] observed no beneficial effect on renal function when applying chronic denervation in a less severe model of septic AKI. Hence, a beneficial effect of acute denervation in the same model seems unlikely.

Finally, given that the perfusion-metabolism mismatch occurred after the hemodynamic effect of denervation had disappeared, our findings fail to provide an answer to the question regarding whether targeting renal perfusion is still beneficial in this more relevant phase.

Conclusions

Acute renal denervation increased RBF and cortical perfusion and attenuated metabolic changes in the renal cortex during early, normotensive sepsis. Medullary perfusion was unaffected, possibly resulting in an intrarenal maldistribution of RBF. Denervation failed to prevent renal hypoperfusion and the associated perfusion-metabolism mismatch that occurred after shock. Renal denervation did not affect kidney function or survival.

Abbreviations

AKI: 

Acute kidney injury

BPU: 

Blood perfusion units

CI: 

Cardiac index

DO2I: 

Oxygen delivery index

FENa: 

Fractional excretion of sodium

FF: 

Filtration fraction

HES: 

Hydroxyethyl starch

L/P: 

Lactate/pyruvate ratio

MAP: 

Mean arterial pressure

O2ER: 

Oxygen extraction ratio

P/F ratio: 

Ratio of arterial oxygen partial pressure to fractional inspired oxygen

PAOP: 

Pulmonary artery balloon-occluded pressure

PDH: 

Pyruvate dehydrogenase

RBF: 

Renal blood flow

RSNA: 

Renal sympathetic nerve activity

SVRI: 

Systemic vascular resistance index

TNa+

Sodium reabsorption

TNa+

Sodium reabsorption

UO: 

Urine output

VO2

Oxygen consumption

VO2I: 

Oxygen consumption index

ΔLactatecortex

Plasma-interstitium pyruvate gradient in the renal cortex

ΔPyruvatecortex

Plasma-interstitium pyruvate gradient in the renal cortex

Declarations

Acknowledgements

None.

Funding

No funding.

Availability of data and materials

The datasets analyzed during the current study are available from the first author on reasonable request.

Authors’ contributions

EHP conceived and designed the study, acquired and interpreted the data and drafted the manuscript; FS, KH, AH participated in the acquisition of the data and drafted the manuscript; FST participated in the design of the study, interpreted the data and drafted the manuscript; JC participated in the design of the study, interpreted the data and drafted the manuscript; DDB and JLV designed the study, interpreted the data and drafted the manuscript. All authors revised the article for critical content. All authors read and approved the final text.

Competing interests

The authors have no conflicts of interest related to this article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The ethical committee of the Free University of Brussels (Comité d’Ethique Hospitalo-Facultaire Erasme-ULB) approved the study protocol.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles

References

  1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.View ArticlePubMedGoogle Scholar
  2. Bagshaw SM, George C, Bellomo R. ANZICS database management committee. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12:R47.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Sakhuja A, Kumar G, Gupta S, Mittal T, Taneja A, Nanchal RS. Acute kidney injury requiring dialysis in severe sepsis. Am J Respir Crit Care Med. 2015;192:951–7.View ArticlePubMedGoogle Scholar
  4. Oppert M, Engel C, Brunkhorst F-M, Bogatsch H, Reinhart K, Frei U, et al. Acute renal failure in patients with severe sepsis and septic shock–a significant independent risk factor for mortality: results from the German prevalence study. Nephrol Dial Transplant. 2008;23:904–9.View ArticlePubMedGoogle Scholar
  5. Wu L, Gokden N, Mayeux PR. Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol. 2007;18:1807–15.View ArticlePubMedGoogle Scholar
  6. Chvojka J, Sykora R, Krouzecky A, Radej J, Varnerova V, Karvunidis T, et al. Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care. 2008;12:R164.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Seely KA, Holthoff JH, Burns ST, Wang Z, Thakali KM, Gokden N, et al. Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. Am J Physiol Ren Physiol. 2011;301:F209–17.View ArticleGoogle Scholar
  8. Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int. 2017;91:45–60.View ArticlePubMedGoogle Scholar
  9. Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69:1996–2002.View ArticlePubMedGoogle Scholar
  10. Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest. 1990;98:170–9.View ArticlePubMedGoogle Scholar
  11. Prowle JR, Molan MP, Hornsey E, Bellomo R. Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation. Crit Care Med. 2012;40:1768–76.View ArticlePubMedGoogle Scholar
  12. Post EH, Su F, Hosokawa K, Taccone FS, Herpain A, Creteur J, et al. Changes in kidney perfusion and renal cortex metabolism in septic shock: an experimental study. J Surg Res. 2017;207:145–54.View ArticlePubMedGoogle Scholar
  13. Day NP, Phu NH, Mai NT, Bethell DB, Chau TT, Loc PP, et al. Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis. Crit Care Med. 2000;28:1353–62.View ArticlePubMedGoogle Scholar
  14. Lauschke A, Teichgräber UKM, Frei U, Eckardt KU. “low-dose”dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69:1669–74.View ArticlePubMedGoogle Scholar
  15. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43:169–75.View ArticlePubMedGoogle Scholar
  16. Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90:513–57.View ArticlePubMedGoogle Scholar
  17. Ramchandra R, Wan L, Hood SG, Frithiof R, Bellomo R, May CN. Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1247–53.Google Scholar
  18. Wang W, Falk SA, Jittikanont S, Gengaro PE, Edelstein CL, Schrier RW. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol Ren Physiol. 2002;283:F583–7.View ArticleGoogle Scholar
  19. Calzavacca P, Bailey M, Velkoska E, Burrell LM, Ramchandra R, Bellomo R, et al. Effects of renal denervation on regional hemodynamics and kidney function in experimental hyperdynamic sepsis. Crit Care Med. 2014;42:e401–9.View ArticlePubMedGoogle Scholar
  20. Kompanowska-Jezierska E, Walkowska A, Johns EJ, Sadowski J. Early effects of renal denervation in the anaesthetised rat: natriuresis and increased cortical blood flow. J Physiol. 2001;531:527–34.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Tsioufis C, Papademetriou V, Dimitriadis K, Tsiachris D, Thomopoulos C, Park E, et al. Catheter-based renal sympathetic denervation exerts acute and chronic effects on renal hemodynamics in swine. Int J Cardiol. 2013;168:987–92.View ArticlePubMedGoogle Scholar
  22. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160:1573–6.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Linz D, Wirth K, Ukena C, Mahfoud F, Pöss J, Linz B, et al. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm. 2013;10:1525–30.View ArticlePubMedGoogle Scholar
  24. Taccone FS, Su F, De Deyne C, Abdellhai A, Pierrakos C, He X, et al. Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis. Crit Care Med. 2014;42:e114–22.View ArticlePubMedGoogle Scholar
  25. Salgado DR, He X, Su F, de Sousa DB, Penaccini L, Maciel LK, et al. Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock. Shock. 2011;35:542–9.View ArticlePubMedGoogle Scholar
  26. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Souba W. Surgical research. New York: Academic Press; 2001.Google Scholar
  28. Hansen DK, Davies MI, Lunte SM, Lunte CE. Pharmacokinetic and metabolism studies using microdialysis sampling. J Pharm Sci. 1999;88:14–27.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Gerlo E, Malfait R. High-performance liquid chromatographic assay of free norepinephrine, epinephrine, dopamine, vanillylmandelic acid and homovanillic acid. J Chromatogr. 1985;343:9–20.View ArticlePubMedGoogle Scholar
  30. Lloyd B, Burrin J, Smythe P, Alberti KG. Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem. 1978;24:1724–9.PubMedGoogle Scholar
  31. Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41:989–1001.View ArticlePubMedGoogle Scholar
  32. Levy B, Sadoune LO, Gelot AM, Bollaert P-E, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28:114–9.View ArticlePubMedGoogle Scholar
  33. Johannes T, Mik EG, Ince C. Nonresuscitated endotoxemia induces microcirculatory hypoxic areas in the renal cortex in the rat. Shock. 2009;31:97–103.View ArticlePubMedGoogle Scholar
  34. Benes J, Chvojka J, Sykora R, Radej J, Krouzecky A, Novak I. Searching for mechanisms that matter in early septic acute kidney injury: an experimental study. Crit Care. 2011;15:R256.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Badr KF. Sepsis-associated renal vasoconstriction: potential targets for future therapy. Am J Kidney Dis. 1992;20:207–13.View ArticlePubMedGoogle Scholar
  36. Boffa JJ, Arendshorst WJ. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol. 2005;16:117–24.View ArticlePubMedGoogle Scholar
  37. Henrich WL, Hamasaki Y, Said SI, Campbell WB, Cronin RE. Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves. J Clin Invest. 1982;69:691–9.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Fantini GA, Shiono S, Bal BS, Shires GT. Adrenergic mechanisms contribute to alterations in regional perfusion during normotensive E. coli bacteremia. J Trauma. 1989;29:1252–7.View ArticlePubMedGoogle Scholar
  39. Post EH, Su F, Taccone FS, Hosokawa K, Herpain A, Creteur J, et al. The effects of fenoldopam on renal function and metabolism in an ovine model of septic shock. Shock. 2016;45:385–92.View ArticlePubMedGoogle Scholar
  40. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12:315–21.View ArticlePubMedGoogle Scholar
  41. James JH, Fang CH, Schrantz SJ, Hasselgren PO, Paul RJ, Fischer JE. Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis. J Clin Invest. 1996;98:2388–97.View ArticlePubMedPubMed CentralGoogle Scholar
  42. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999;354:505–8.View ArticlePubMedGoogle Scholar
  43. Johns EJ, Kopp UC, DiBona GF. Neural control of renal function. Compr Physiol. 2011;1:731–67.PubMedGoogle Scholar
  44. Johannes T, Mik EG, Nohé B, Raat NJH, Unertl KE, Ince C. Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia. Crit Care. 2006;10:R88.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med. 2011;37:60–7.View ArticlePubMedGoogle Scholar
  46. Evans RG, Gardiner BS, Smith DW, O’Connor PM. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Ren Physiol. 2008;295:F1259–70.View ArticleGoogle Scholar
  47. Calzavacca P, Evans RG, Bailey M, Bellomo R, May CN. Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury. Crit Care Med. 2015;43:e431-9Google Scholar
  48. Cain SM. Effects of time and vasoconstrictor tone on O2 extraction during hypoxic hypoxia. J Appl Physiol. 1978;45:219–24.PubMedGoogle Scholar
  49. Maginniss LA, Connolly H, Samsel RW, Schumacker PT. Adrenergic vasoconstriction augments tissue O2 extraction during reductions in O2 delivery. J Appl Physiol. 1994;76:1454–61.PubMedGoogle Scholar
  50. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N. Engl J Med. 2012;367:124–34.View ArticleGoogle Scholar
  51. Wang Z, Sims CR, Patil NK, Gokden N, Mayeux PR. Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J Pharmacol Exp Ther. 2014;352:61–6.View ArticlePubMedGoogle Scholar
  52. Albuszies G, Vogt J, Wachter U, Thiemermann C, Leverve XM, Weber S, et al. The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock. Intensive Care Med. 2007;33:1094–101.View ArticlePubMedGoogle Scholar
  53. Simkova V, Baumgart K, Vogt J, Wachter U, Weber S, Gröger M, et al. The effect of superoxide dismutase overexpression on hepatic gluconeogenesis and whole-body glucose oxidation during resuscitated normotensive murine septic shock. Shock. 2008;30:578–84.View ArticlePubMedGoogle Scholar
  54. Kelmer-Bracht AM, Broetto-Biazon AC, Sá-Nakanishi D, Babeto A, Ishii-Iwamoto EL, Bracht A. Low doses of tumour necrosis factor α and interleukin 1β diminish hepatic gluconeogenesis from alanine in vivo. Basic Clin Pharmacol Toxicol. 2006;99:335–9.View ArticlePubMedGoogle Scholar
  55. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-lactic acidosis study group. N Engl J Med. 1992;327:1564–9.View ArticlePubMedGoogle Scholar
  56. Curtis SE, Cain SM. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Am Rev Respir Dis. 1992;145:348–54.View ArticlePubMedGoogle Scholar
  57. Vary TC. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock. 1996;6:89–94.View ArticlePubMedGoogle Scholar
  58. Trayhurn P, Ashwell M. Control of white and brown adipose tissues by the autonomic nervous system. Proc Nutr Soc. 1987;46:135–42.View ArticlePubMedGoogle Scholar
  59. Assimacopoulos-Jeannet F, McCormack JG, Jeanrenaud B. Effect of phenylephrine on pyruvate dehydrogenase activity in rat hepatocytes and its interaction with insulin and glucagon. FEBS Lett. 1983;159:83–8.View ArticlePubMedGoogle Scholar
  60. Di Lisa F, Fan CZ, Gambassi G, Hogue BA, Kudryashova I, Hansford RG. Altered pyruvate dehydrogenase control and mitochondrial free Ca2+ in hearts of cardiomyopathic hamsters. Am J Physiol. 1993;264:H2188–97.Google Scholar
  61. Baines AD, Ross BD. Gluconeogenesis and phosphate reabsorption in isolated lactate- or pyruvate-perfused rat kidneys. Miner Electrolyte Metab. 1984;10:286–91.PubMedGoogle Scholar
  62. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int. 2011;79:S1–6.View ArticleGoogle Scholar
  63. Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care. 2014;18:503.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement